These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30949077)

  • 1. A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy.
    Sessa B; Higbed L; Nutt D
    Front Psychiatry; 2019; 10():138. PubMed ID: 30949077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.
    Inouye A; Wolfgang A
    Cureus; 2022 Jun; 14(6):e26402. PubMed ID: 35915689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials.
    Yang J; Wang N; Luo W; Gao J
    Psychiatry Res; 2024 Jun; 339():116043. PubMed ID: 38896930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns.
    Baldo BA
    Arch Toxicol; 2024 May; ():. PubMed ID: 38743292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder.
    Amoroso T
    J Psychoactive Drugs; 2015; 47(5):337-44. PubMed ID: 26579955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials.
    Stauffer CS; Brown MR; Adams D; Cassity M; Sevelius J
    Front Psychiatry; 2022; 13():932605. PubMed ID: 36299539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder.
    Lewis BR; Byrne K
    Focus (Am Psychiatr Publ); 2023 Jul; 21(3):247-256. PubMed ID: 37404966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
    Feduccia AA; Jerome L; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    Front Psychiatry; 2019; 10():650. PubMed ID: 31572236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
    Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
    Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy.
    Gully BJ; Eaton E; Capone C; Haass-Koffler CL
    J Psychopharmacol; 2023 Dec; 37(12):1182-1189. PubMed ID: 38009477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence.
    Riaz K; Suneel S; Hamza Bin Abdul Malik M; Kashif T; Ullah I; Waris A; Di Nicola M; Mazza M; Sani G; Martinotti G; De Berardis D
    Diseases; 2023 Nov; 11(4):. PubMed ID: 37987270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
    Feduccia AA; Jerome L; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    Focus (Am Psychiatr Publ); 2023 Jul; 21(3):306-314. PubMed ID: 37404974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine-Assisted Therapy for Posttraumatic Stress Disorder: A Review of the Evidence, Neurobiological Plausibility, and Clinical Significance.
    Price CM; Feduccia AA; DeBonis K
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):464-469. PubMed ID: 36018231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis.
    Smith KW; Sicignano DJ; Hernandez AV; White CM
    J Clin Pharmacol; 2022 Apr; 62(4):463-471. PubMed ID: 34708874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for Post-traumatic Stress Disorder in Humans: A Systematic Review and Meta-Analysis.
    Tedesco S; Gajaram G; Chida S; Ahmad A; Pentak M; Kelada M; Lewis L; Krishnan D; Tran C; Soetan OT; Mukona LT; Jolayemi A
    Cureus; 2021 May; 13(5):e15070. PubMed ID: 34150406
    [No Abstract]   [Full Text] [Related]  

  • 16. First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants.
    Sessa B; Sakal C; O'Brien S; Nutt D
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31308191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
    Oehen P; Traber R; Widmer V; Schnyder U
    J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and promise for the MDMA drug development program.
    Feduccia AA; Holland J; Mithoefer MC
    Psychopharmacology (Berl); 2018 Feb; 235(2):561-571. PubMed ID: 29152674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why MDMA therapy for alcohol use disorder? And why now?
    Sessa B
    Neuropharmacology; 2018 Nov; 142():83-88. PubMed ID: 29126911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.
    Sessa B; Higbed L; O'Brien S; Durant C; Sakal C; Titheradge D; Williams TM; Rose-Morris A; Brew-Girard E; Burrows S; Wiseman C; Wilson S; Rickard J; Nutt DJ
    J Psychopharmacol; 2021 Apr; 35(4):375-383. PubMed ID: 33601929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.